Xolair 75 MG/0.5 ML syringe 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FYQ07
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $38,685
Award facts
- Contract value 100% obligated
- $38,685.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency valued at $38,685.00 for XOLAIR 75 MG/0.5 ML syringes. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of October 2, 2025, and was executed on September 11, 2025. This award carries no set-aside designation, allowing DMS Pharmaceutical Group to compete on an open basis despite its small business status. The place of performance is the vendor's location in Park Ridge, Illinois.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, a $499.9 billion vehicle valid through November 2026. This master contract enables the DLA to procure a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables to support military health facilities worldwide. XOLAIR, a biologic asthma and allergic condition treatment, represents one of the specialized pharmaceutical products covered under this overarching contract vehicle, demonstrating DMS Pharmaceutical Group's role as a critical supplier within the Department of Defense pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DB25FYQ07?
SPE2DB25FYQ07 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 11, 2025.
How much is contract SPE2DB25FYQ07 worth?
The government has obligated $38,685 on SPE2DB25FYQ07.
Is contract SPE2DB25FYQ07 an order under another contract?
Yes. SPE2DB25FYQ07 is a delivery order under SPE2DB22D9316, an indefinite delivery contract.
Was contract SPE2DB25FYQ07 competed?
The extent of competition for SPE2DB25FYQ07 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award